UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 5, 2024

Accession Number:	0001193125-24-057844
Submission Type:	POS AM
CIK: 0001624422 Company Name: PHAXIAM Therapeutics S.A. File Number: 333-259690